Logo

Large Scale Biology, Novozymes Biotech Collaborate on Gene Improvement Research

Jan 29, 2003

SAN FRANCISCO, Jan. 29 - Large Scale Biology said today it is collaborating with Novozymes Biotech on gene improvement studies.

 

LSB will use its molecular evolution technology to study genes provided by Davis, Calif.-based Novozymes Biotech in an attempt to modify the properties of proteins.

 

Financial details of the agreement were not disclosed.

Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.